Diagnostic Imaging Global Market – Forecast To 2022
Diagnostic imaging is a non-invasive diagnosis and treatment of some of the most life threatening diseases such as cancer and heart diseases and they have nearly eliminated the need for exploratory surgery. It is identified as one of the largest markets among the healthcare sector. Imaging techniques would allow diagnosing, treating and curing patients without causing any harmful side effects. The different diagnostic imaging modalities include X-ray systems, Computed Tomography (CT) Scanners, Magnetic Resonance Imaging (MRI) systems, Ultrasound systems and Nuclear imaging systems. According to IQ4I estimates, the diagnostic imaging global market is expected to reach $38,315 million by 2022.
Globally Diagnostic imaging technologies market is segmented into product outlook, technology outlook, applications and end-users. Product outlook is further segmented into Computed Tomography (CT) scanners, Nuclear Imaging (NI) equipment, Magnetic Resonance Imaging (MRI) systems, Ultrasound scanners and X-ray devices and others. Technology outlook is also alienated again into Computed Tomography (CT), Nuclear Imaging (NI), Magnetic Resonance Imaging (MRI), Ultrasound, x-ray and others. Application outlook is classified into Cardiovascular Diseases (CVD’s), Cancer, Neurological disorders, abdominal related problems, Orthopedic related problems, gynecology related problems and others. Depending on the end-users, the market is segmented into hospitals, private diagnostic laboratories and research laboratories.
Globally among the diagnostic imaging techniques, ultrasound is the most frequently used imaging procedure with more than 900 million exams per year followed by X-ray, CT, MRI, and nuclear medicine. This indicates that diagnostic imaging market contributes to its highest share among all imaging techniques.
This report studies the Diagnostic imaging technologies global market over the forecast period (2016-2022). The market is expected to grow at a mid single digit CAGR from 2015 to 2022. Increasing incidence of life threatening diseases with growth of aged cohort, growing awareness among people about early disease diagnosis and improving healthcare expenditure in emerging markets, high number of ongoing research activities across the globe are the factors driving the market growth. High cost of diagnostic imaging systems, imposition of excise tax on sale of medical devices and risk of radiation exposure limiting the usage of some diagnostic imaging systems are the factors hampering the market growth.
North America holds the largest share in the global diagnostic imaging market, followed by Europe. However, the Asia-Pacific market is expected to grow at the highest CAGR of 5.8% from 2015 to 2022. The Asian and Latin American countries represent the fastest growing markets due to increasing government support for research and rising industry and academic partnerships for pre-clinical research. But still the factors such as economic slowdown, pricing pressures may compel the companies to focus on Asian markets.
The top key market players in the global diagnostic imaging market are Analogic Corporation (U.S.), GE Healthcare (U.K), Philips Healthcare (Netherland), Siemens Healthcare (U.S.), Toshiba Medical Systems Corporation (Japan), Hitachi Medical Corporation (Japan), Carestream Health, Inc. (U.S.), Hologic, Inc. (U.S.), Samsung Medison (South Korea) and Shimadzu Corporation (Japan). Among them GE Healthcare (U.K.) holds the leadership position in the global market by launching many new products into the market.
Globally Diagnostic imaging technologies market is segmented into product outlook, technology outlook, applications and end-users. Product outlook is further segmented into Computed Tomography (CT) scanners, Nuclear Imaging (NI) equipment, Magnetic Resonance Imaging (MRI) systems, Ultrasound scanners and X-ray devices and others. Technology outlook is also alienated again into Computed Tomography (CT), Nuclear Imaging (NI), Magnetic Resonance Imaging (MRI), Ultrasound, x-ray and others. Application outlook is classified into Cardiovascular Diseases (CVD’s), Cancer, Neurological disorders, abdominal related problems, Orthopedic related problems, gynecology related problems and others. Depending on the end-users, the market is segmented into hospitals, private diagnostic laboratories and research laboratories.
Globally among the diagnostic imaging techniques, ultrasound is the most frequently used imaging procedure with more than 900 million exams per year followed by X-ray, CT, MRI, and nuclear medicine. This indicates that diagnostic imaging market contributes to its highest share among all imaging techniques.
This report studies the Diagnostic imaging technologies global market over the forecast period (2016-2022). The market is expected to grow at a mid single digit CAGR from 2015 to 2022. Increasing incidence of life threatening diseases with growth of aged cohort, growing awareness among people about early disease diagnosis and improving healthcare expenditure in emerging markets, high number of ongoing research activities across the globe are the factors driving the market growth. High cost of diagnostic imaging systems, imposition of excise tax on sale of medical devices and risk of radiation exposure limiting the usage of some diagnostic imaging systems are the factors hampering the market growth.
North America holds the largest share in the global diagnostic imaging market, followed by Europe. However, the Asia-Pacific market is expected to grow at the highest CAGR of 5.8% from 2015 to 2022. The Asian and Latin American countries represent the fastest growing markets due to increasing government support for research and rising industry and academic partnerships for pre-clinical research. But still the factors such as economic slowdown, pricing pressures may compel the companies to focus on Asian markets.
The top key market players in the global diagnostic imaging market are Analogic Corporation (U.S.), GE Healthcare (U.K), Philips Healthcare (Netherland), Siemens Healthcare (U.S.), Toshiba Medical Systems Corporation (Japan), Hitachi Medical Corporation (Japan), Carestream Health, Inc. (U.S.), Hologic, Inc. (U.S.), Samsung Medison (South Korea) and Shimadzu Corporation (Japan). Among them GE Healthcare (U.K.) holds the leadership position in the global market by launching many new products into the market.
1 EXECUTIVE SUMMARY
2 INTRODUCTION
2.1 KEY TAKE AWAYS
2.2 REPORT DESCRIPTION
2.3 MARKETS COVERED
2.4 STAKEHOLDERS
2.5 RESEARCH METHODOLOGY
2.5.1 MARKET SIZE ESTIMATION
2.5.2 MARKET BREAKDOWN AND DATATRIANGULATION
2.5.3 SECONDARY SOURCES
2.5.4 PRIMARY SOURCES
2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES
2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.5.7 ASSUMPTIONS
3 MARKET ANALYSIS
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
3.3.1 DRIVERS AND OPPORTUNITIES
3.3.1.1 Increasing incidence of life threatening diseases with growth of aged cohort
3.3.1.2 Growing awareness among people about early disease diagnosis and improving healthcare expenditure in emerging markets
3.3.1.3 Increasing investments by government as well as private bodies in mature and emerging markets to modernize diagnostic imaging
3.3.1.4 Increasing number of private diagnostic centers offering diagnostic imaging services
3.3.1.5 High number of ongoing research activities across the globe
3.3.1.6 Increasing application of diagnostic imaging systems
3.3.1.7 Technological advancements in diagnostic imaging modalities with its use in multiple fields to increase its adoption by hospitals
3.3.1.8 Extenuating the alleged risks associated with diagnostic imaging and implementing sustainable practices
3.3.1.9 Dedicated R&D and product development by key players
3.3.2 RESTRAINTS AND THREATS
3.3.2.1 High cost of diagnostic imaging systems
3.3.2.2 Imposition of excise tax on the sale of medical imaging systems
3.3.2.3 Risk of radiation exposure limiting the use of some diagnostic imaging systems
3.3.2.4 Lack of skilled personnel and reimbursement cuts for diagnostic imaging procedures in some countries
3.3.3 PROBLEM AREAS
3.3.3.1 Shortage in supply of technetium99m for SPECT systems
3.3.3.2 Shortage of helium for MRI systems
3.3.4 WINNING IMPERATIVE
3.3.4.1 Increasing adoption of refurbished diagnostic imaging systems
3.3.4.2 Focusing on emerging markets
3.4 REGULATORY AFFAIRS
3.4.1 U.S.
3.4.2 EUROPE
3.4.3 CHINA
3.4.4 INDIA
3.4.5 JAPAN
3.5 PORTER’S FIVE FORCE ANALYSIS
3.5.1 THREAT OF NEW ENTRANTS
3.5.2 THREAT OF SUBSTITUTES
3.5.3 RIVALRY AMONG EXISTING COMPETITORS
3.5.4 BARGAINING POWER OF SUPPLIERS
3.5.5 BARGAINING POWER OF BUYERS
3.6 SUPPLY CHAIN ANALYSIS
3.7 PATENT TRENDS
3.8 EMERGING TECHNOLOGIES
3.8.1 ULTRASOUND
3.8.1.1 Automated breast ultrasound
3.8.1.2 Robotic ultrasound
3.8.1.3 Remote ultrasound
3.8.2 MRI
3.8.2.1 Ultra low field MRI
3.8.2.2 Magnetoencephalography (MEG)
3.8.2.3 Computer aided detection (CAD) for MRI
3.8.3 NUCLEAR IMAGING
3.8.3.1 Handheld gamma cameras
3.8.4 CT SCANS
3.8.4.1 Breast tomosynthesis
3.8.5 HYBRID SYSTEMS
3.8.5.1 PET/MRI
3.8.5.2 Photo acoustic tomography(PAT)
3.9 UPCOMING TECHNOLOGIES
3.10 MARKET SHARE ANALYSIS BY MAJOR PLAYERS
3.10.1 CT MARKET SHARE ANALYSIS BY MAJOR PLAYERS
3.10.2 MRI MARKET SHARE ANALYSIS BY MAJOR PLAYERS
3.10.3 ULTRASOUND MARKET SHARE ANALYSIS BY MAJOR PLAYERS
3.10.4 NUCLEAR IMAGING MARKET SHARE ANALYSIS BY MAJOR PLAYERS
3.10.5 X-RAY MARKET SHARE ANALYSIS BY MAJOR PLAYERS
3.10.6 MAMMOGRAPHY MARKET SHARE ANALYSIS BY MAJOR PLAYERS
4 DIAGNOSTIC IMAGING GLOBAL MARKET, BY PRODUCTS
4.1 INTRODUCTION
4.2 COMPUTED TOMOGRAPHY (CT) SCANNERS
4.2.1 STATIONARY COMPUTED TOMOGRAPHY
4.2.2 PORTable COMPUTED TOMOGRAPHY
4.3 NUCLEAR IMAGING (NI) EQUIPMENT
4.3.1 SINGLE PHOTON-EMISSION COMPUTED TOMOGRAPHY (SPECT)
4.3.2 POSITRON-EMISSION TOMOGRAPHY (PET)
4.4 MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS
4.4.1 OPEN SIDED MRI SYSTEM
4.4.2 CLOSED SYSTEM
4.4.3 OPEN STANDBY/ SITTING MRI
4.5 ULTRASOUND SCANNERS
4.5.1 TROLLEY/CART BASED ULTRASOUND SCANNERS
4.5.2 COMPACT/ PORTable ULTRASOUND SCANNER
4.6 X-RAY DEVICES
4.6.1 STATIONARY DEVICES
4.6.2 PORTable DEVICES
4.6.2.1 Mobile devices
4.6.2.2 Handheld devices
4.7 OTHERS
5 DIAGNOSTIC IMAGING GLOBAL MARKET, BY TECHNOLOGY
5.1 INTRODUCTION
5.2 CT
5.2.1 LOW SLICE CT
5.2.2 MEDIUM SLICE CT
5.2.3 HIGH SLICE CT
5.3 NUCLEAR IMAGING
5.3.1 SPECT
5.3.2 PET
5.4 MRI
5.4.1 LOW AND MIDDLE FIELD MRI
5.4.2 HIGH FIELD MRI
5.4.3 VERY HIGH FIELD MRI
5.5 ULTRASOUND
5.5.1 2D ULTRASOUND
5.5.2 3D AND 4D IMAGING
5.5.3 DOPPLER IMAGING
5.5.4 HIFU IMAGING
5.5.5 CONTRAST ULTRASOUND
5.5.6 ULTRASOUND ELASTOGRAPHY
5.5.7 OTHERS
5.6 X RAY
5.6.1 DIGITAL RADIOGRAPHY
5.6.2 COMPUTED RADIOGRAPHY
5.6.3 ANALOG RADIOGRAPHY
5.7 OTHERS
6 DIAGNOSTIC IMAGING GLOBAL MARKET, BY APPLICATION
6.1 INTRODUCTION
6.2 CARDIOVASCULAR DISEASES (CVD)
6.3 CANCER (ONCOLOGY)
6.4 NEUROLOGICAL DISORDERS
6.5 ABDOMINAL RELATED PROBLEMS
6.6 ORTHOPEDIC DISORDERS
6.7 GYNECOLOGY
6.8 OTHERS
7 DIAGNOSTIC IMAGING GLOBAL MARKET, BY END-USERS
7.1 INTRODUCTION
7.2 HOSPITALS
7.3 PRIVATE DIAGNOSTIC LABORATORIES
7.4 RESEARCH LABORATORIES
8 REGIONAL MARKET ANALYSIS
8.1 INTRODUCTION
8.2 NORTH AMERICA
8.2.1 U.S.
8.3 EUROPE
8.4 ASIA PACIFIC
8.5 REST OF WORLD (ROW)
9 COMPANY DEVELOPMENTS
9.1 INTRODUCTION
9.1.1 NEW PRODUCT LAUNCH AS A MAJOR GROWTH STRATEGY OF DIAGNOSTIC IMAGING MARKET PLAYERS
9.2 NEW PRODUCT LAUNCH
9.3 APPROVALS
9.4 EXHIBITIONS
9.5 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES
9.6 MERGERS AND ACQUISITIONS
9.7 OTHER DEVELOPMENTS
10 MAJOR COMPANIES
10.1 ANALOGIC CORPORATION
10.1.1 OVERVIEW
10.1.2 FINANCIALS
10.1.3 PRODUCT PORTFOLIO
10.1.4 KEY DEVELOPMENTS
10.1.5 BUSINESS STRATEGY
10.1.6 SWOT ANALYSIS
10.2 CARESTREAM HEALTH, INC.
10.2.1 OVERVIEW
10.2.2 FINANCIALS
10.2.3 PRODUCT PORFOLIO
10.2.4 KEY DEVELOPMENTS
10.2.5 BUSINESS STRATEGY
10.2.6 SWOT ANALYSIS
10.3 GE HEALTHCARE
10.3.1 OVERVIEW
10.3.2 FINANCIALS
10.3.3 PRODUCT PORTFOLIO
10.3.4 KEY DEVELOPMENTS
10.3.5 BUSINESS STRATEGY
10.3.6 SWOT ANALYSIS
10.4 HITACHI MEDICAL CORPORATION
10.4.1 OVERVIEW
10.4.2 FINANCIALS
10.4.3 PRODUCT PORTFOLIO
10.4.4 KEY DEVELOPMENTS
10.4.5 BUSINESS STRATEGY
10.4.6 SWOT ANALYSIS
10.5 HOLOGIC, INC.
10.5.1 OVERVIEW
10.5.2 FINANCIALS
10.5.3 PRODUCT PORTFOLIO
10.5.4 KEY DEVELOPMENTS
10.5.5 BUSINESS STRATEGY
10.5.6 SWOT ANALYSIS
10.6 PHILIPS HEALTHCARE
10.6.1 OVERVIEW
10.6.2 FINANCIALS
10.6.3 PRODUCT PORTFOLIO
10.6.4 KEY DEVELOPMENTS
10.6.5 BUSINESS STRATEGY
10.6.6 SWOT ANALYSIS
10.7 SAMSUNG MEDISON
10.7.1 OVERVIEW
10.7.2 FINANCIALS
10.7.3 PRODUCT PORTFOLIO
10.7.4 KEY DEVELOPMENTS
10.7.5 BUSINESS STRATEGY
10.7.6 SWOT ANALYSIS
10.8 SHIMADZU CORPORATION
10.8.1 OVERVIEW
10.8.2 FINANCIALS
10.8.3 PRODUCT PORTFOLIO
10.8.4 KEY DEVELOPMENTS
10.8.5 BUSINESS STRATEGY
10.8.6 SWOT ANALYSIS
10.9 SIEMENS HEALTHCARE
10.9.1 OVERVIEW
10.9.2 FINANCIALS
10.9.3 PRODUCT PORTFOLIO
10.9.4 KEY DEVELOPMENTS
10.9.5 BUSINESS STRATEGY
10.9.6 SWOT ANALYSIS
10.10 TOSHIBA MEDICAL SYSTEMS CORPORATION
10.10.1 OVERVIEW
10.10.2 FINANCIALS
10.10.3 PRODUCT PORTFOLIO
10.10.4 KEY DEVELOPMENTS
10.10.5 BUSINESS STRATEGY
10.10.6 SWOT ANALYSIS
2 INTRODUCTION
2.1 KEY TAKE AWAYS
2.2 REPORT DESCRIPTION
2.3 MARKETS COVERED
2.4 STAKEHOLDERS
2.5 RESEARCH METHODOLOGY
2.5.1 MARKET SIZE ESTIMATION
2.5.2 MARKET BREAKDOWN AND DATATRIANGULATION
2.5.3 SECONDARY SOURCES
2.5.4 PRIMARY SOURCES
2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES
2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.5.7 ASSUMPTIONS
3 MARKET ANALYSIS
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
3.3.1 DRIVERS AND OPPORTUNITIES
3.3.1.1 Increasing incidence of life threatening diseases with growth of aged cohort
3.3.1.2 Growing awareness among people about early disease diagnosis and improving healthcare expenditure in emerging markets
3.3.1.3 Increasing investments by government as well as private bodies in mature and emerging markets to modernize diagnostic imaging
3.3.1.4 Increasing number of private diagnostic centers offering diagnostic imaging services
3.3.1.5 High number of ongoing research activities across the globe
3.3.1.6 Increasing application of diagnostic imaging systems
3.3.1.7 Technological advancements in diagnostic imaging modalities with its use in multiple fields to increase its adoption by hospitals
3.3.1.8 Extenuating the alleged risks associated with diagnostic imaging and implementing sustainable practices
3.3.1.9 Dedicated R&D and product development by key players
3.3.2 RESTRAINTS AND THREATS
3.3.2.1 High cost of diagnostic imaging systems
3.3.2.2 Imposition of excise tax on the sale of medical imaging systems
3.3.2.3 Risk of radiation exposure limiting the use of some diagnostic imaging systems
3.3.2.4 Lack of skilled personnel and reimbursement cuts for diagnostic imaging procedures in some countries
3.3.3 PROBLEM AREAS
3.3.3.1 Shortage in supply of technetium99m for SPECT systems
3.3.3.2 Shortage of helium for MRI systems
3.3.4 WINNING IMPERATIVE
3.3.4.1 Increasing adoption of refurbished diagnostic imaging systems
3.3.4.2 Focusing on emerging markets
3.4 REGULATORY AFFAIRS
3.4.1 U.S.
3.4.2 EUROPE
3.4.3 CHINA
3.4.4 INDIA
3.4.5 JAPAN
3.5 PORTER’S FIVE FORCE ANALYSIS
3.5.1 THREAT OF NEW ENTRANTS
3.5.2 THREAT OF SUBSTITUTES
3.5.3 RIVALRY AMONG EXISTING COMPETITORS
3.5.4 BARGAINING POWER OF SUPPLIERS
3.5.5 BARGAINING POWER OF BUYERS
3.6 SUPPLY CHAIN ANALYSIS
3.7 PATENT TRENDS
3.8 EMERGING TECHNOLOGIES
3.8.1 ULTRASOUND
3.8.1.1 Automated breast ultrasound
3.8.1.2 Robotic ultrasound
3.8.1.3 Remote ultrasound
3.8.2 MRI
3.8.2.1 Ultra low field MRI
3.8.2.2 Magnetoencephalography (MEG)
3.8.2.3 Computer aided detection (CAD) for MRI
3.8.3 NUCLEAR IMAGING
3.8.3.1 Handheld gamma cameras
3.8.4 CT SCANS
3.8.4.1 Breast tomosynthesis
3.8.5 HYBRID SYSTEMS
3.8.5.1 PET/MRI
3.8.5.2 Photo acoustic tomography(PAT)
3.9 UPCOMING TECHNOLOGIES
3.10 MARKET SHARE ANALYSIS BY MAJOR PLAYERS
3.10.1 CT MARKET SHARE ANALYSIS BY MAJOR PLAYERS
3.10.2 MRI MARKET SHARE ANALYSIS BY MAJOR PLAYERS
3.10.3 ULTRASOUND MARKET SHARE ANALYSIS BY MAJOR PLAYERS
3.10.4 NUCLEAR IMAGING MARKET SHARE ANALYSIS BY MAJOR PLAYERS
3.10.5 X-RAY MARKET SHARE ANALYSIS BY MAJOR PLAYERS
3.10.6 MAMMOGRAPHY MARKET SHARE ANALYSIS BY MAJOR PLAYERS
4 DIAGNOSTIC IMAGING GLOBAL MARKET, BY PRODUCTS
4.1 INTRODUCTION
4.2 COMPUTED TOMOGRAPHY (CT) SCANNERS
4.2.1 STATIONARY COMPUTED TOMOGRAPHY
4.2.2 PORTable COMPUTED TOMOGRAPHY
4.3 NUCLEAR IMAGING (NI) EQUIPMENT
4.3.1 SINGLE PHOTON-EMISSION COMPUTED TOMOGRAPHY (SPECT)
4.3.2 POSITRON-EMISSION TOMOGRAPHY (PET)
4.4 MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS
4.4.1 OPEN SIDED MRI SYSTEM
4.4.2 CLOSED SYSTEM
4.4.3 OPEN STANDBY/ SITTING MRI
4.5 ULTRASOUND SCANNERS
4.5.1 TROLLEY/CART BASED ULTRASOUND SCANNERS
4.5.2 COMPACT/ PORTable ULTRASOUND SCANNER
4.6 X-RAY DEVICES
4.6.1 STATIONARY DEVICES
4.6.2 PORTable DEVICES
4.6.2.1 Mobile devices
4.6.2.2 Handheld devices
4.7 OTHERS
5 DIAGNOSTIC IMAGING GLOBAL MARKET, BY TECHNOLOGY
5.1 INTRODUCTION
5.2 CT
5.2.1 LOW SLICE CT
5.2.2 MEDIUM SLICE CT
5.2.3 HIGH SLICE CT
5.3 NUCLEAR IMAGING
5.3.1 SPECT
5.3.2 PET
5.4 MRI
5.4.1 LOW AND MIDDLE FIELD MRI
5.4.2 HIGH FIELD MRI
5.4.3 VERY HIGH FIELD MRI
5.5 ULTRASOUND
5.5.1 2D ULTRASOUND
5.5.2 3D AND 4D IMAGING
5.5.3 DOPPLER IMAGING
5.5.4 HIFU IMAGING
5.5.5 CONTRAST ULTRASOUND
5.5.6 ULTRASOUND ELASTOGRAPHY
5.5.7 OTHERS
5.6 X RAY
5.6.1 DIGITAL RADIOGRAPHY
5.6.2 COMPUTED RADIOGRAPHY
5.6.3 ANALOG RADIOGRAPHY
5.7 OTHERS
6 DIAGNOSTIC IMAGING GLOBAL MARKET, BY APPLICATION
6.1 INTRODUCTION
6.2 CARDIOVASCULAR DISEASES (CVD)
6.3 CANCER (ONCOLOGY)
6.4 NEUROLOGICAL DISORDERS
6.5 ABDOMINAL RELATED PROBLEMS
6.6 ORTHOPEDIC DISORDERS
6.7 GYNECOLOGY
6.8 OTHERS
7 DIAGNOSTIC IMAGING GLOBAL MARKET, BY END-USERS
7.1 INTRODUCTION
7.2 HOSPITALS
7.3 PRIVATE DIAGNOSTIC LABORATORIES
7.4 RESEARCH LABORATORIES
8 REGIONAL MARKET ANALYSIS
8.1 INTRODUCTION
8.2 NORTH AMERICA
8.2.1 U.S.
8.3 EUROPE
8.4 ASIA PACIFIC
8.5 REST OF WORLD (ROW)
9 COMPANY DEVELOPMENTS
9.1 INTRODUCTION
9.1.1 NEW PRODUCT LAUNCH AS A MAJOR GROWTH STRATEGY OF DIAGNOSTIC IMAGING MARKET PLAYERS
9.2 NEW PRODUCT LAUNCH
9.3 APPROVALS
9.4 EXHIBITIONS
9.5 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES
9.6 MERGERS AND ACQUISITIONS
9.7 OTHER DEVELOPMENTS
10 MAJOR COMPANIES
10.1 ANALOGIC CORPORATION
10.1.1 OVERVIEW
10.1.2 FINANCIALS
10.1.3 PRODUCT PORTFOLIO
10.1.4 KEY DEVELOPMENTS
10.1.5 BUSINESS STRATEGY
10.1.6 SWOT ANALYSIS
10.2 CARESTREAM HEALTH, INC.
10.2.1 OVERVIEW
10.2.2 FINANCIALS
10.2.3 PRODUCT PORFOLIO
10.2.4 KEY DEVELOPMENTS
10.2.5 BUSINESS STRATEGY
10.2.6 SWOT ANALYSIS
10.3 GE HEALTHCARE
10.3.1 OVERVIEW
10.3.2 FINANCIALS
10.3.3 PRODUCT PORTFOLIO
10.3.4 KEY DEVELOPMENTS
10.3.5 BUSINESS STRATEGY
10.3.6 SWOT ANALYSIS
10.4 HITACHI MEDICAL CORPORATION
10.4.1 OVERVIEW
10.4.2 FINANCIALS
10.4.3 PRODUCT PORTFOLIO
10.4.4 KEY DEVELOPMENTS
10.4.5 BUSINESS STRATEGY
10.4.6 SWOT ANALYSIS
10.5 HOLOGIC, INC.
10.5.1 OVERVIEW
10.5.2 FINANCIALS
10.5.3 PRODUCT PORTFOLIO
10.5.4 KEY DEVELOPMENTS
10.5.5 BUSINESS STRATEGY
10.5.6 SWOT ANALYSIS
10.6 PHILIPS HEALTHCARE
10.6.1 OVERVIEW
10.6.2 FINANCIALS
10.6.3 PRODUCT PORTFOLIO
10.6.4 KEY DEVELOPMENTS
10.6.5 BUSINESS STRATEGY
10.6.6 SWOT ANALYSIS
10.7 SAMSUNG MEDISON
10.7.1 OVERVIEW
10.7.2 FINANCIALS
10.7.3 PRODUCT PORTFOLIO
10.7.4 KEY DEVELOPMENTS
10.7.5 BUSINESS STRATEGY
10.7.6 SWOT ANALYSIS
10.8 SHIMADZU CORPORATION
10.8.1 OVERVIEW
10.8.2 FINANCIALS
10.8.3 PRODUCT PORTFOLIO
10.8.4 KEY DEVELOPMENTS
10.8.5 BUSINESS STRATEGY
10.8.6 SWOT ANALYSIS
10.9 SIEMENS HEALTHCARE
10.9.1 OVERVIEW
10.9.2 FINANCIALS
10.9.3 PRODUCT PORTFOLIO
10.9.4 KEY DEVELOPMENTS
10.9.5 BUSINESS STRATEGY
10.9.6 SWOT ANALYSIS
10.10 TOSHIBA MEDICAL SYSTEMS CORPORATION
10.10.1 OVERVIEW
10.10.2 FINANCIALS
10.10.3 PRODUCT PORTFOLIO
10.10.4 KEY DEVELOPMENTS
10.10.5 BUSINESS STRATEGY
10.10.6 SWOT ANALYSIS
LIST OF TABLES
Table 1 DIAGNOSTIC IMAGING GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 2 DIAGNOSTIC IMAGING GLOBAL MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 3 DIAGNOSTIC IMAGING GLOBAL MARKET REVENUE, BY APPLICATION, (2014-2022) ($MN)
Table 4 DIAGNOSTIC IMAGING GLOBAL MARKET REVENUE, BY END-USERS, (2014-2022) ($MN)
Table 5 DIAGNOSTIC IMAGING GLOBAL MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 6 COMPUTED TOMOGRAPHY (CT) SCANNERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 7 COMPUTED TOMOGRAPHY (CT) SCANNERS GLOBAL MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 8 STATIONARY COMPUTED TOMOGRAPHY (CT) SCANNERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 9 PORTable COMPUTED TOMOGRAPHY (CT) SCANNERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 10 NUCLEAR IMAGING (NI) EQUIPMENT GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 11 NUCLEAR IMAGING (NI) EQUIPMENT GLOBAL MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 12 SPECT IMAGING EQUIPMENT GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 13 PET IMAGING EQUIPMENT GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 14 MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 15 MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS GLOBAL MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 16 MRI OPEN SYSTEM GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 17 MRI CLOSED SYSTEM GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 18 OPEN MRI STANDBY/ SITTING SYSTEM GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 19 ULTRASOUND SCANNERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 20 ULTRASOUND SCANNERS GLOBAL MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 21 TROLLEY/ CART BASED ULTRASOUND SCANNERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 22 COMPACT/ PORTable ULTRASOUND SCANNERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 23 X-RAY DEVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 24 X-RAY DEVICES GLOBAL MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 25 STATIONARY X-RAY DEVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 26 PORTable X-RAY DEVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 27 PORTable X-RAY DEVICES GLOBAL MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 28 PORTable MOBILE X-RAY DEVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 29 PORTable HANDHELD X-RAY DEVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 30 OTHER DIAGNOSTIC IMAGING GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 31 DIAGNOSTIC IMAGING GLOBAL MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 32 COMPUTED TOMOGRAPHY (CT) GLOBAL MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 33 LOW SLICE CT GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 34 MEDIUM SLICE CT GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 35 HIGH SLICE CT GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 36 NUCLEAR IMAGING (NI) GLOBAL MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 37 SPECT IMAGING GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 38 PET IMAGING GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 39 MAGNETIC RESONANCE IMAGING (MRI) GLOBAL MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 40 LOW AND MIDDLE FIELD MRI GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 41 HIGH FIELD MRI GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 42 VERY HIGH FIELD MRI GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 43 ULTRASOUND SCANNERS GLOBAL MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 44 2D ULTRASOUND GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 45 3D AND 4D ULTRASOUND GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 46 DOPPLER ULTRASONOGRAPHY GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 47 HIFU IMAGING GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 48 CONTRAST ULTRASOUND GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 49 ULTRASOUND ELASTOGRAPHY GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 50 OTHER ULTRASOUND GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 51 X-RAY IMAGING GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 52 X-RAY IMAGING GLOBAL MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 53 DIGITAL RADIOGRAPHY X-RAY GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 54 COMPUTED RADIOGRAPHY X-RAY GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 55 ANALOG IMAGING X-RAY GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 56 OTHER DIAGNOSTIC IMAGING GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 57 DIAGNOSTIC IMAGING GLOBAL MARKET REVENUE, BY APPLICATION, (2014-2022) ($MN)
Table 58 CARDIOVASCULAR DIAGNOSTIC IMAGING APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 59 CANCER DIAGNOSTIC IMAGING APPLICATION GLOBAL MARKET REVENUE, BY REGION (2014-2022) ($MN)
Table 60 NEUROLOGICAL DISORDERS DIAGNOSTIC IMAGING APPLICATION GLOBAL MARKET REVENUE, BY REGION (2014-2022) ($MN)
Table 61 ABDOMINAL RELATED PROBLEMS DIAGNOSTIC IMAGING APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 62 ORTHOPEDIC DIAGNOSTIC IMAGING APPLICATION GLOBAL MARKET REVENUE, BY REGION (2014-2022) ($MN)
Table 63 GYNECOLOGY DIAGNOSTIC IMAGING APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 64 OTHER DIAGNOSTIC IMAGING APPLICATIONS GLOBAL MARKET REVENUE, BY REGION (2014-2022) ($MN)
Table 65 DIAGNOSTIC IMAGING GLOBAL MARKET REVENUE, BY END USERS, (2014-2022) ($MN)
Table 66 HOSPITALS DIAGNOSTIC IMAGING GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 67 PRIVATE DIAGNOSTIC LABORATORIES GLOBAL MARKET REVENUE, BY REGION (2014-2022) ($MN)
Table 68 RESEARCH LABORATORIES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 69 DIAGNOSTIC IMAGING GLOBAL MARKET REVENUE, BY REGION, (2014–2022) ($MN)
Table 70 NORTH AMERICAN DIAGNOSTIC IMAGING MARKET REVENUE, BY PRODUCT, (2014–2022) ($MN)
Table 71 NORTH AMERICAN COMPUTED TOMOGRAPHY (CT) SCANNERS MARKET, BY PRODUCT, (2014–2022) ($MN)
Table 72 NORTH AMERICAN NUCLEAR IMAGING (NI) EQUIPMENT MARKET REVENUE, BY PRODUCT (2014-2022) ($MN)
Table 73 NORTH AMERICAN MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 74 NORTH AMERICAN ULTRASOUND SCANNERS MARKET REVENUE, BY PRODUCT,(2014-2022) ($MN)
Table 75 NORTH AMERICAN X-RAY DEVICES MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 76 NORTH AMERICAN PORTable X-RAY DEVICES MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 77 NORTH AMERICAN DIAGNOSTIC IMAGING MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 78 NORTH AMERICAN COMPUTED TOMOGRAPHY (CT) MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 79 NORTH AMERICAN NUCLEAR IMAGING (NI) MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 80 NORTH AMERICAN MAGNETIC RESONANCE IMAGING (MRI) MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 81 NORTH AMERICAN ULTRASOUND MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 82 NORTH AMERICAN X-RAY IMAGING MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 83 NORTH AMERICAN DIAGNOSTIC IMAGING MARKET REVENUE, BY APPLICATION, (2014-2022) ($MN)
Table 84 NORTH AMERICAN DIAGNOSTIC IMAGING MARKET REVENUE, BY END-USERS, (2014-2022) ($MN)
Table 85 EUROPEAN DIAGNOSTIC IMAGING MARKET REVENUE, BY PRODUCT, (2014–2022) ($MN)
Table 86 EUROPEAN COMPUTED TOMOGRAPHY (CT) SCANNERS MARKET, BY PRODUCT, (2014–2022) ($MN)
Table 87 EUROPEAN NUCLEAR IMAGING (NI) EQUIPMENT MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 88 EUROPEAN MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 89 EUROPEAN ULTRASOUND SCANNERS MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 90 EUROPEAN X-RAY DEVICES MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 91 EUROPEAN PORTable X-RAY DEVICES MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 92 EUROPEAN DIAGNOSTIC IMAGING MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 93 EUROPEAN COMPUTED TOMOGRAPHY (CT) MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 94 EUROPEAN NUCLEAR IMAGING (NI) MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 95 EUROPEAN MAGNETIC RESONANCE IMAGING (MRI) MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 96 EUROPEAN ULTRASOUND MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 97 EUROPEAN X-RAY IMAGING MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 98 EUROPEAN DIAGNOSTIC IMAGING MARKET REVENUE, BY APPLICATION, (2014-2022) ($MN)
Table 99 EUROPEAN DIAGNOSTIC IMAGING MARKET REVENUE, BY END-USERS, (2014-2022) ($MN)
Table 100 ASIA PACIFIC DIAGNOSTIC IMAGING MARKET REVENUE, BY PRODUCT, (2014–2022) ($MN)
Table 101 ASIA PACIFIC COMPUTED TOMOGRAPHY (CT) SCANNERS MARKET, BY PRODUCT, (2014–2022) ($MN)
Table 102 ASIA PACIFIC NUCLEAR IMAGING (NI) MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 103 ASIA PACIFIC MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 104 ASIA PACIFIC ULTRASOUND SCANNERS MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 105 ASIA PACIFIC X-RAY DEVICES MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 106 ASIA PACIFIC PORTable X-RAY DEVICES MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 107 ASIA PACIFIC DIAGNOSTIC IMAGING MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 108 ASIA PACIFIC COMPUTED TOMOGRAPHY (CT) MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 109 ASIA PACIFIC NUCLEAR IMAGING (NI) MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 110 ASIA PACIFIC MAGNETIC RESONANCE IMAGING (MRI) MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 111 ASIA PACIFIC ULTRASOUND MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 112 ASIA PACIFIC X-RAY IMAGING MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 113 ASIA PACIFIC DIAGNOSTIC IMAGING MARKET REVENUE, BY APPLICATION, (2014-2022) ($MN)
Table 114 ASIA PACIFIC DIAGNOSTIC IMAGING MARKET REVENUE, BY END-USERS, (2014-2022) ($MN)
Table 115 ROW DIAGNOSTIC IMAGING MARKET REVENUE, BY PRODUCT, (2014–2022) ($MN)
Table 116 ROW COMPUTED TOMOGRAPHY (CT) SCANNERS MARKET, BY PRODUCT, (2014–2022) ($MN)
Table 117 ROW NUCLEAR IMAGING (NI) MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 118 ROW MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 119 ROW ULTRASOUND SCANNERS MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 120 ROW X-RAY DEVICES MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 121 ROW PORTable X-RAY DEVICES MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 122 ROW DIAGNOSTIC IMAGING MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 123 ROW COMPUTED TOMOGRAPHY (CT) MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 124 ROW NUCLEAR IMAGING (NI) MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 125 ROW MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 126 ROW ULTRASOUND MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 127 ROW X-RAY IMAGING MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 128 ROW DIAGNOSTIC IMAGING MARKET REVENUE, BY APPLICATION, (2014-2022) ($MN)
Table 129 ROW DIAGNOSTIC IMAGING MARKET REVENUE, BY END-USERS, (2014-2022) ($MN)
Table 130 NEW PRODUCT LAUNCHES (2013-2016)
Table 131 APPROVALS (2013-2016)
Table 132 EXHIBITIONS (2013-2015)
Table 133 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, & JOINT VENTURES (2013-2015)
Table 134 MERGERS AND ACQUISITIONS (2013-2015)
Table 135 OTHER DEVELOPMENTS (2013-2015)
Table 136 ANALOGIC CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 137 ANALOGIC CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
Table 138 ANALOGIC CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
Table 139 GENERAL ELECTRIC COMPANY: TOTAL REVENUE AND R&D EXPENSES, (2013–2015) ($MN)
Table 140 GENERAL ELECTRIC COMPANY: TOTAL REVENUE, BY SEGMENT, (2013-2015) ($MN)
Table 141 GENERAL ELECTRIC COMPANY: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
Table 142 HITACHI MEDICAL CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 143 HITACHI MEDICAL CORPORATION: TOTAL REVENUE, BY SEGMENT, (2013-2015) ($MN)
Table 144 HITACHI MEDICAL CORPORATION: TOTAL REVENUE, BY REGION, (2013-2015) ($MN)
Table 145 HOLOGIC, INC.: TOTAL REVENUE AND R&D EXPENSES (2013-2015) ($MN)
Table 146 HOLOGIC, INC.: PRODUCT SALES REVENUE, BY SEGMENT, (2013-2015) ($MN)
Table 147 HOLOGIC, INC.: TOTAL REVENUE, BY REGION, (2013-2015) ($MN)
Table 148 PHILIPS N.V.: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 149 PHILIPS N.V.: TOTAL REVENUE, BY SEGMENT, (2013-2015) ($MN)
Table 150 PHILIPS HEALTHCARE: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
Table 151 SAMSUNG: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 152 SAMSUNG: TOTAL REVENUE, BY SEGMENT, (2013-2015) ($MN)
Table 153 SAMSUNG: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
Table 154 SHIMADZU CORPORATION: TOTAL REVENUE AND OPERATING EXPENSES, (2013-2015) ($MN)
Table 155 SHIMADZU CORPORATION: TOTAL REVENUE, BY SEGMENT, (2013-2015) ($MN)
Table 156 SHIMADZU CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
Table 157 SIEMENS AG: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 158 SIEMENS AG: TOTAL REVENUE, BY SEGMENT, (2013-2015) ($MN)
Table 159 SIEMENS AG: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
Table 160 TOSHIBA CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 161 TOSHIBA CORPORATION: TOTAL REVENUE, BY SEGMENT, (2013-2015) ($MN)
Table 162 TOSHIBA CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
Table 1 DIAGNOSTIC IMAGING GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 2 DIAGNOSTIC IMAGING GLOBAL MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 3 DIAGNOSTIC IMAGING GLOBAL MARKET REVENUE, BY APPLICATION, (2014-2022) ($MN)
Table 4 DIAGNOSTIC IMAGING GLOBAL MARKET REVENUE, BY END-USERS, (2014-2022) ($MN)
Table 5 DIAGNOSTIC IMAGING GLOBAL MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 6 COMPUTED TOMOGRAPHY (CT) SCANNERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 7 COMPUTED TOMOGRAPHY (CT) SCANNERS GLOBAL MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 8 STATIONARY COMPUTED TOMOGRAPHY (CT) SCANNERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 9 PORTable COMPUTED TOMOGRAPHY (CT) SCANNERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 10 NUCLEAR IMAGING (NI) EQUIPMENT GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 11 NUCLEAR IMAGING (NI) EQUIPMENT GLOBAL MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 12 SPECT IMAGING EQUIPMENT GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 13 PET IMAGING EQUIPMENT GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 14 MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 15 MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS GLOBAL MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 16 MRI OPEN SYSTEM GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 17 MRI CLOSED SYSTEM GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 18 OPEN MRI STANDBY/ SITTING SYSTEM GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 19 ULTRASOUND SCANNERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 20 ULTRASOUND SCANNERS GLOBAL MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 21 TROLLEY/ CART BASED ULTRASOUND SCANNERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 22 COMPACT/ PORTable ULTRASOUND SCANNERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 23 X-RAY DEVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 24 X-RAY DEVICES GLOBAL MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 25 STATIONARY X-RAY DEVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 26 PORTable X-RAY DEVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 27 PORTable X-RAY DEVICES GLOBAL MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 28 PORTable MOBILE X-RAY DEVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 29 PORTable HANDHELD X-RAY DEVICES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 30 OTHER DIAGNOSTIC IMAGING GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 31 DIAGNOSTIC IMAGING GLOBAL MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 32 COMPUTED TOMOGRAPHY (CT) GLOBAL MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 33 LOW SLICE CT GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 34 MEDIUM SLICE CT GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 35 HIGH SLICE CT GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 36 NUCLEAR IMAGING (NI) GLOBAL MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 37 SPECT IMAGING GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 38 PET IMAGING GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 39 MAGNETIC RESONANCE IMAGING (MRI) GLOBAL MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 40 LOW AND MIDDLE FIELD MRI GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 41 HIGH FIELD MRI GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 42 VERY HIGH FIELD MRI GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 43 ULTRASOUND SCANNERS GLOBAL MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 44 2D ULTRASOUND GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 45 3D AND 4D ULTRASOUND GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 46 DOPPLER ULTRASONOGRAPHY GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 47 HIFU IMAGING GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 48 CONTRAST ULTRASOUND GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 49 ULTRASOUND ELASTOGRAPHY GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 50 OTHER ULTRASOUND GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 51 X-RAY IMAGING GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 52 X-RAY IMAGING GLOBAL MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 53 DIGITAL RADIOGRAPHY X-RAY GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 54 COMPUTED RADIOGRAPHY X-RAY GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 55 ANALOG IMAGING X-RAY GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 56 OTHER DIAGNOSTIC IMAGING GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 57 DIAGNOSTIC IMAGING GLOBAL MARKET REVENUE, BY APPLICATION, (2014-2022) ($MN)
Table 58 CARDIOVASCULAR DIAGNOSTIC IMAGING APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 59 CANCER DIAGNOSTIC IMAGING APPLICATION GLOBAL MARKET REVENUE, BY REGION (2014-2022) ($MN)
Table 60 NEUROLOGICAL DISORDERS DIAGNOSTIC IMAGING APPLICATION GLOBAL MARKET REVENUE, BY REGION (2014-2022) ($MN)
Table 61 ABDOMINAL RELATED PROBLEMS DIAGNOSTIC IMAGING APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 62 ORTHOPEDIC DIAGNOSTIC IMAGING APPLICATION GLOBAL MARKET REVENUE, BY REGION (2014-2022) ($MN)
Table 63 GYNECOLOGY DIAGNOSTIC IMAGING APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 64 OTHER DIAGNOSTIC IMAGING APPLICATIONS GLOBAL MARKET REVENUE, BY REGION (2014-2022) ($MN)
Table 65 DIAGNOSTIC IMAGING GLOBAL MARKET REVENUE, BY END USERS, (2014-2022) ($MN)
Table 66 HOSPITALS DIAGNOSTIC IMAGING GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 67 PRIVATE DIAGNOSTIC LABORATORIES GLOBAL MARKET REVENUE, BY REGION (2014-2022) ($MN)
Table 68 RESEARCH LABORATORIES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
Table 69 DIAGNOSTIC IMAGING GLOBAL MARKET REVENUE, BY REGION, (2014–2022) ($MN)
Table 70 NORTH AMERICAN DIAGNOSTIC IMAGING MARKET REVENUE, BY PRODUCT, (2014–2022) ($MN)
Table 71 NORTH AMERICAN COMPUTED TOMOGRAPHY (CT) SCANNERS MARKET, BY PRODUCT, (2014–2022) ($MN)
Table 72 NORTH AMERICAN NUCLEAR IMAGING (NI) EQUIPMENT MARKET REVENUE, BY PRODUCT (2014-2022) ($MN)
Table 73 NORTH AMERICAN MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 74 NORTH AMERICAN ULTRASOUND SCANNERS MARKET REVENUE, BY PRODUCT,(2014-2022) ($MN)
Table 75 NORTH AMERICAN X-RAY DEVICES MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 76 NORTH AMERICAN PORTable X-RAY DEVICES MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 77 NORTH AMERICAN DIAGNOSTIC IMAGING MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 78 NORTH AMERICAN COMPUTED TOMOGRAPHY (CT) MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 79 NORTH AMERICAN NUCLEAR IMAGING (NI) MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 80 NORTH AMERICAN MAGNETIC RESONANCE IMAGING (MRI) MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 81 NORTH AMERICAN ULTRASOUND MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 82 NORTH AMERICAN X-RAY IMAGING MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 83 NORTH AMERICAN DIAGNOSTIC IMAGING MARKET REVENUE, BY APPLICATION, (2014-2022) ($MN)
Table 84 NORTH AMERICAN DIAGNOSTIC IMAGING MARKET REVENUE, BY END-USERS, (2014-2022) ($MN)
Table 85 EUROPEAN DIAGNOSTIC IMAGING MARKET REVENUE, BY PRODUCT, (2014–2022) ($MN)
Table 86 EUROPEAN COMPUTED TOMOGRAPHY (CT) SCANNERS MARKET, BY PRODUCT, (2014–2022) ($MN)
Table 87 EUROPEAN NUCLEAR IMAGING (NI) EQUIPMENT MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 88 EUROPEAN MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 89 EUROPEAN ULTRASOUND SCANNERS MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 90 EUROPEAN X-RAY DEVICES MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 91 EUROPEAN PORTable X-RAY DEVICES MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 92 EUROPEAN DIAGNOSTIC IMAGING MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 93 EUROPEAN COMPUTED TOMOGRAPHY (CT) MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 94 EUROPEAN NUCLEAR IMAGING (NI) MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 95 EUROPEAN MAGNETIC RESONANCE IMAGING (MRI) MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 96 EUROPEAN ULTRASOUND MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 97 EUROPEAN X-RAY IMAGING MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 98 EUROPEAN DIAGNOSTIC IMAGING MARKET REVENUE, BY APPLICATION, (2014-2022) ($MN)
Table 99 EUROPEAN DIAGNOSTIC IMAGING MARKET REVENUE, BY END-USERS, (2014-2022) ($MN)
Table 100 ASIA PACIFIC DIAGNOSTIC IMAGING MARKET REVENUE, BY PRODUCT, (2014–2022) ($MN)
Table 101 ASIA PACIFIC COMPUTED TOMOGRAPHY (CT) SCANNERS MARKET, BY PRODUCT, (2014–2022) ($MN)
Table 102 ASIA PACIFIC NUCLEAR IMAGING (NI) MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 103 ASIA PACIFIC MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 104 ASIA PACIFIC ULTRASOUND SCANNERS MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 105 ASIA PACIFIC X-RAY DEVICES MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 106 ASIA PACIFIC PORTable X-RAY DEVICES MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 107 ASIA PACIFIC DIAGNOSTIC IMAGING MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 108 ASIA PACIFIC COMPUTED TOMOGRAPHY (CT) MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 109 ASIA PACIFIC NUCLEAR IMAGING (NI) MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 110 ASIA PACIFIC MAGNETIC RESONANCE IMAGING (MRI) MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 111 ASIA PACIFIC ULTRASOUND MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 112 ASIA PACIFIC X-RAY IMAGING MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 113 ASIA PACIFIC DIAGNOSTIC IMAGING MARKET REVENUE, BY APPLICATION, (2014-2022) ($MN)
Table 114 ASIA PACIFIC DIAGNOSTIC IMAGING MARKET REVENUE, BY END-USERS, (2014-2022) ($MN)
Table 115 ROW DIAGNOSTIC IMAGING MARKET REVENUE, BY PRODUCT, (2014–2022) ($MN)
Table 116 ROW COMPUTED TOMOGRAPHY (CT) SCANNERS MARKET, BY PRODUCT, (2014–2022) ($MN)
Table 117 ROW NUCLEAR IMAGING (NI) MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 118 ROW MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 119 ROW ULTRASOUND SCANNERS MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 120 ROW X-RAY DEVICES MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 121 ROW PORTable X-RAY DEVICES MARKET REVENUE, BY PRODUCT, (2014-2022) ($MN)
Table 122 ROW DIAGNOSTIC IMAGING MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 123 ROW COMPUTED TOMOGRAPHY (CT) MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 124 ROW NUCLEAR IMAGING (NI) MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 125 ROW MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 126 ROW ULTRASOUND MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 127 ROW X-RAY IMAGING MARKET REVENUE, BY TECHNOLOGY, (2014-2022) ($MN)
Table 128 ROW DIAGNOSTIC IMAGING MARKET REVENUE, BY APPLICATION, (2014-2022) ($MN)
Table 129 ROW DIAGNOSTIC IMAGING MARKET REVENUE, BY END-USERS, (2014-2022) ($MN)
Table 130 NEW PRODUCT LAUNCHES (2013-2016)
Table 131 APPROVALS (2013-2016)
Table 132 EXHIBITIONS (2013-2015)
Table 133 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, & JOINT VENTURES (2013-2015)
Table 134 MERGERS AND ACQUISITIONS (2013-2015)
Table 135 OTHER DEVELOPMENTS (2013-2015)
Table 136 ANALOGIC CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 137 ANALOGIC CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
Table 138 ANALOGIC CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
Table 139 GENERAL ELECTRIC COMPANY: TOTAL REVENUE AND R&D EXPENSES, (2013–2015) ($MN)
Table 140 GENERAL ELECTRIC COMPANY: TOTAL REVENUE, BY SEGMENT, (2013-2015) ($MN)
Table 141 GENERAL ELECTRIC COMPANY: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
Table 142 HITACHI MEDICAL CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 143 HITACHI MEDICAL CORPORATION: TOTAL REVENUE, BY SEGMENT, (2013-2015) ($MN)
Table 144 HITACHI MEDICAL CORPORATION: TOTAL REVENUE, BY REGION, (2013-2015) ($MN)
Table 145 HOLOGIC, INC.: TOTAL REVENUE AND R&D EXPENSES (2013-2015) ($MN)
Table 146 HOLOGIC, INC.: PRODUCT SALES REVENUE, BY SEGMENT, (2013-2015) ($MN)
Table 147 HOLOGIC, INC.: TOTAL REVENUE, BY REGION, (2013-2015) ($MN)
Table 148 PHILIPS N.V.: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 149 PHILIPS N.V.: TOTAL REVENUE, BY SEGMENT, (2013-2015) ($MN)
Table 150 PHILIPS HEALTHCARE: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
Table 151 SAMSUNG: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 152 SAMSUNG: TOTAL REVENUE, BY SEGMENT, (2013-2015) ($MN)
Table 153 SAMSUNG: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
Table 154 SHIMADZU CORPORATION: TOTAL REVENUE AND OPERATING EXPENSES, (2013-2015) ($MN)
Table 155 SHIMADZU CORPORATION: TOTAL REVENUE, BY SEGMENT, (2013-2015) ($MN)
Table 156 SHIMADZU CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
Table 157 SIEMENS AG: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 158 SIEMENS AG: TOTAL REVENUE, BY SEGMENT, (2013-2015) ($MN)
Table 159 SIEMENS AG: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
Table 160 TOSHIBA CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 161 TOSHIBA CORPORATION: TOTAL REVENUE, BY SEGMENT, (2013-2015) ($MN)
Table 162 TOSHIBA CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
LIST OF FIGURES
Figure 1 GLOBAL DIAGNOSTIC IMAGING MARKET SHARE AND REVENUE, BY REGION (2014-2022) ($MN)
Figure 2 DIAGNOSTIC IMAGING GLOBAL MARKET REVENUE, BY TECHNOLOGY, (2015) ($MN)
Figure 3 DIAGNOSTIC IMAGING GLOBAL MARKET: RESEARCH APPROACH
Figure 4 DIAGNOSTIC IMAGING GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
Figure 5 DIAGNOSTIC IMAGING GLOBAL MARKET: FORECASTING MODEL
Figure 6 DIAGNOSTIC IMAGING GLOBAL MARKET: MARKET BREAKDOWN & DATA TRIANGULATION
Figure 7 DIAGNOSTIC IMAGING MARKET: MARKET SEGMENTATION
Figure 8 MARKET DYNAMICS
Figure 9 DIAGNOSTIC IMAGING GLOBAL MARKET: PORTER’S ANALYSIS
Figure 10 DIAGNOSTIC IMAGING GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
Figure 11 DIAGNOSTIC IMAGING (CT,MRI,ULTRASOUND,X-RAY,NUCLEAR IMAGING, MAMMOGRAPHY): PCT APPLICATION FILING BY MODALITIES, (2011-2015)
Figure 12 COMPUTED TOMOGRAPHY (DIAGNOSTIC IMAGING): PCT APPLICATION FILING BY MAJOR PLAYERS, (2011-2015)
Figure 13 MAGNETIC RESONANCE IMAGING (DIAGNOSTIC IMAGING): PCT APPLICATION FILING BY MAJOR PLAYERS, (2011-2015)
Figure 14 ULTRASOUND IMAGING (DIAGNOSTIC IMAGING): PCT APPLICATION FILING BY MAJOR PLAYERS, (2011-2015)
Figure 15 X-RAY (DIAGNOSTIC IMAGING): PCT APPLICATION FILING BY MAJOR PLAYERS, (2011-2015)
Figure 16 NUCLEAR IMAGING (DIAGNOSTIC IMAGING): PCT APPLICATION FILING BY MAJOR PLAYERS, (2011-2015)
Figure 17 MAMMOGRAPHY (DIAGNOSTIC IMAGING): PCT APPLICATION FILING BY MAJOR PLAYERS, (2011-2015)
Figure 18 DIAGNOSTIC IMAGING GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2015 (%)
Figure 19 CT GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2015 (%)
Figure 20 MRI GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2015 (%)
Figure 21 ULTRASOUND GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2015 (%)
Figure 22 GLOBAL NUCLEAR IMAGING MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2015 (%)
Figure 23 GLOBAL X-RAY IMAGING MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2015 (%)
Figure 24 MAMMOGRAPHY GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2015 (%)
Figure 25 DIAGNOSTIC IMAGING GLOBAL MARKET SCENARIO, BY PRODUCT OUTLOOK (2015)
Figure 26 NUCLEAR IMAGING (NI) EQUIPMENT GLOBAL MARKET SHARE, BY PRODUCT TYPE, (2015 V’S 2022) (%)
Figure 27 MRI GLOBAL MARKET SHARE, BY PRODUCT TYPE, (2015 V’S 2022) (%)
Figure 28 COMPUTED TOMOGRAPHY (CT) GLOBAL MARKET SHARE, BY TECHNOLOGY TYPE, (2015 V’S 2022) (%)
Figure 29 MAGNETIC RESONANCE IMAGING (MRI) GLOBAL MARKET SHARE, BY TECHNOLOGY, (2015 V’S 2022) (%)
Figure 30 ULTRASOUND SCANNERS GLOBAL MARKET SHARE, BY TECHNOLOGY, 2015 (%)
Figure 31 X-RAY IMAGING GLOBAL MARKET SHARE, BY TECHNOLOGY, (2014-2022) (%)
Figure 32 DIAGNOSTIC IMAGING GLOBAL MARKET SHARE, BY APPLICATION, 2015 (%), CAGR (%)
Figure 33 DIAGNOSTIC IMAGING GLOABL MARKET REVENUE, BY END USERS, (2015 V’S 2022) ($MN)
Figure 34 DIAGNOSTIC IMAGING GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN), CAGR (%)
Figure 35 NORTH AMERICAN DIAGNOSTIC IMAGING GLOBAL MARKET REVENUE, BY TECHNOLOGY, APPLICATION & END USERS, (2015 V’S 2022) ($MN)
Figure 36 EUROPEAN DIAGNOSTIC IMAGING GLOBAL MARKET REVENUE, BY APPLICATION, TECHNOLOGY & END USERS (2015 V’S 2022) ($MN)
Figure 37 ASIA PACIFIC DIAGNOSTIC IMAGING MARKET REVENUE, BY TECHNOLOGY, APPLICATION & END-USERS, (2015 V’S 2022), ($MN)
Figure 38 ROW DIAGNOSTIC IMAGING GLOBAL MARKET REVENUE, BY APPLICATION, TECHNOLOGY & END-USERS, (2015 V’S 2022), ($MN)
Figure 39 KEY GROWTH STRATEGIES, (2013-2016)
Figure 40 SWOT: ANALOGIC CORPORATION
Figure 41 SWOT: CARESTREAM HEALTH, INC.
Figure 42 SWOT: GE HEALTHCARE
Figure 43 SWOT: HITACHI MEDICAL CORPORATION, INC.
Figure 44 SWOT: HOLOGIC, INC.
Figure 45 SWOT: PHILIPS HEALTHCARE
Figure 46 SWOT: SAMSUNG MEDISON
Figure 47 SWOT: SHIMADZU CORPORATION
Figure 48 SWOT: SIEMENS HEALTHCARE
Figure 49 SWOT: TOSHIBA MEDICAL SYSTEMS CORPORATION
Figure 1 GLOBAL DIAGNOSTIC IMAGING MARKET SHARE AND REVENUE, BY REGION (2014-2022) ($MN)
Figure 2 DIAGNOSTIC IMAGING GLOBAL MARKET REVENUE, BY TECHNOLOGY, (2015) ($MN)
Figure 3 DIAGNOSTIC IMAGING GLOBAL MARKET: RESEARCH APPROACH
Figure 4 DIAGNOSTIC IMAGING GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
Figure 5 DIAGNOSTIC IMAGING GLOBAL MARKET: FORECASTING MODEL
Figure 6 DIAGNOSTIC IMAGING GLOBAL MARKET: MARKET BREAKDOWN & DATA TRIANGULATION
Figure 7 DIAGNOSTIC IMAGING MARKET: MARKET SEGMENTATION
Figure 8 MARKET DYNAMICS
Figure 9 DIAGNOSTIC IMAGING GLOBAL MARKET: PORTER’S ANALYSIS
Figure 10 DIAGNOSTIC IMAGING GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
Figure 11 DIAGNOSTIC IMAGING (CT,MRI,ULTRASOUND,X-RAY,NUCLEAR IMAGING, MAMMOGRAPHY): PCT APPLICATION FILING BY MODALITIES, (2011-2015)
Figure 12 COMPUTED TOMOGRAPHY (DIAGNOSTIC IMAGING): PCT APPLICATION FILING BY MAJOR PLAYERS, (2011-2015)
Figure 13 MAGNETIC RESONANCE IMAGING (DIAGNOSTIC IMAGING): PCT APPLICATION FILING BY MAJOR PLAYERS, (2011-2015)
Figure 14 ULTRASOUND IMAGING (DIAGNOSTIC IMAGING): PCT APPLICATION FILING BY MAJOR PLAYERS, (2011-2015)
Figure 15 X-RAY (DIAGNOSTIC IMAGING): PCT APPLICATION FILING BY MAJOR PLAYERS, (2011-2015)
Figure 16 NUCLEAR IMAGING (DIAGNOSTIC IMAGING): PCT APPLICATION FILING BY MAJOR PLAYERS, (2011-2015)
Figure 17 MAMMOGRAPHY (DIAGNOSTIC IMAGING): PCT APPLICATION FILING BY MAJOR PLAYERS, (2011-2015)
Figure 18 DIAGNOSTIC IMAGING GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2015 (%)
Figure 19 CT GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2015 (%)
Figure 20 MRI GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2015 (%)
Figure 21 ULTRASOUND GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2015 (%)
Figure 22 GLOBAL NUCLEAR IMAGING MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2015 (%)
Figure 23 GLOBAL X-RAY IMAGING MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2015 (%)
Figure 24 MAMMOGRAPHY GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2015 (%)
Figure 25 DIAGNOSTIC IMAGING GLOBAL MARKET SCENARIO, BY PRODUCT OUTLOOK (2015)
Figure 26 NUCLEAR IMAGING (NI) EQUIPMENT GLOBAL MARKET SHARE, BY PRODUCT TYPE, (2015 V’S 2022) (%)
Figure 27 MRI GLOBAL MARKET SHARE, BY PRODUCT TYPE, (2015 V’S 2022) (%)
Figure 28 COMPUTED TOMOGRAPHY (CT) GLOBAL MARKET SHARE, BY TECHNOLOGY TYPE, (2015 V’S 2022) (%)
Figure 29 MAGNETIC RESONANCE IMAGING (MRI) GLOBAL MARKET SHARE, BY TECHNOLOGY, (2015 V’S 2022) (%)
Figure 30 ULTRASOUND SCANNERS GLOBAL MARKET SHARE, BY TECHNOLOGY, 2015 (%)
Figure 31 X-RAY IMAGING GLOBAL MARKET SHARE, BY TECHNOLOGY, (2014-2022) (%)
Figure 32 DIAGNOSTIC IMAGING GLOBAL MARKET SHARE, BY APPLICATION, 2015 (%), CAGR (%)
Figure 33 DIAGNOSTIC IMAGING GLOABL MARKET REVENUE, BY END USERS, (2015 V’S 2022) ($MN)
Figure 34 DIAGNOSTIC IMAGING GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN), CAGR (%)
Figure 35 NORTH AMERICAN DIAGNOSTIC IMAGING GLOBAL MARKET REVENUE, BY TECHNOLOGY, APPLICATION & END USERS, (2015 V’S 2022) ($MN)
Figure 36 EUROPEAN DIAGNOSTIC IMAGING GLOBAL MARKET REVENUE, BY APPLICATION, TECHNOLOGY & END USERS (2015 V’S 2022) ($MN)
Figure 37 ASIA PACIFIC DIAGNOSTIC IMAGING MARKET REVENUE, BY TECHNOLOGY, APPLICATION & END-USERS, (2015 V’S 2022), ($MN)
Figure 38 ROW DIAGNOSTIC IMAGING GLOBAL MARKET REVENUE, BY APPLICATION, TECHNOLOGY & END-USERS, (2015 V’S 2022), ($MN)
Figure 39 KEY GROWTH STRATEGIES, (2013-2016)
Figure 40 SWOT: ANALOGIC CORPORATION
Figure 41 SWOT: CARESTREAM HEALTH, INC.
Figure 42 SWOT: GE HEALTHCARE
Figure 43 SWOT: HITACHI MEDICAL CORPORATION, INC.
Figure 44 SWOT: HOLOGIC, INC.
Figure 45 SWOT: PHILIPS HEALTHCARE
Figure 46 SWOT: SAMSUNG MEDISON
Figure 47 SWOT: SHIMADZU CORPORATION
Figure 48 SWOT: SIEMENS HEALTHCARE
Figure 49 SWOT: TOSHIBA MEDICAL SYSTEMS CORPORATION
